PeptiDream Inc
TSE:4587

Watchlist Manager
PeptiDream Inc Logo
PeptiDream Inc
TSE:4587
Watchlist
Price: 2 738 JPY 6.81% Market Closed
Market Cap: 354.9B JPY
Have any thoughts about
PeptiDream Inc?
Write Note

Gross Margin
PeptiDream Inc

74.4%
Current
67%
Average
63.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
74.4%
=
Gross Profit
35.5B
/
Revenue
47.8B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
JP
PeptiDream Inc
TSE:4587
354.9B JPY
74%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
US
Abbvie Inc
NYSE:ABBV
312.7B USD
67%
US
Amgen Inc
NASDAQ:AMGN
158.3B USD
60%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD
86%
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD
78%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
AU
CSL Ltd
ASX:CSL
133.6B AUD
52%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD
87%
US
Seagen Inc
F:SGT
39.3B EUR
75%
NL
argenx SE
XBRU:ARGX
34.8B EUR
89%
Country JP
Market Cap 354.9B JPY
Gross Margin
74%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 312.7B USD
Gross Margin
67%
Country US
Market Cap 158.3B USD
Gross Margin
60%
Country US
Market Cap 116.2B USD
Gross Margin
86%
Country US
Market Cap 112.4B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 133.6B AUD
Gross Margin
52%
Country US
Market Cap 81.3B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.8B EUR
Gross Margin
89%
No Stocks Found

PeptiDream Inc
Glance View

Market Cap
354.9B JPY
Industry
Biotechnology

PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. The company is headquartered in Kawasaki-Shi, Kanagawa-Ken and currently employs 141 full-time employees. The company went IPO on 2013-06-11. The firm operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The firm is involved in the business centered on drug development based on special peptides. The firm's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).

Intrinsic Value
2 322.19 JPY
Overvaluation 15%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
74.4%
=
Gross Profit
35.5B
/
Revenue
47.8B
What is the Gross Margin of PeptiDream Inc?

Based on PeptiDream Inc's most recent financial statements, the company has Gross Margin of 74.4%.